(Press-News.org) Philadelphia, Pa. -- More than one out of every 10 seniors (10.5%) enrolled in a Medicare Advantage plan, also known as a Medicare managed care option, and living in a rural area, switched to traditional Medicare during 2010-2016. The switch was driven primarily due to low satisfaction with care access, according to a study published this week in Health Affairs from researchers at Drexel University's Dornsife School of Public Health. By contrast, only 1.7% of rural traditional Medicare enrollees made the switch to Medicare Advantage during this period.
The findings, among the first to look at rates of switching between the two options among rural versus nonrural enrollees, found a similar, yet more muted, effect among nonrural enrollees, with 2.2% of traditional Medicare enrollees and 5% of Medicare Advantage enrollees making the switch.
Switching was most common among Medicare Advantage enrollees who experienced higher costs, such as hospitalization or long-term facility stay. Among those requiring more expensive services, rural enrollees were about twice as likely to switch from Medicare Advantage to traditional Medicare as nonrural enrollees (16.8% versus 8.3%), suggesting that limited provider options in rural areas were a major factor leading consumers to change their coverage plan.
"We studied 11 factors that might make someone switch their health insurance and found that much of this transfer from Medicare Advantage to traditional Medicare among rural residents came from limited provider availability. However, care quality or out-of-pocket costs played a limited role." said lead author Sungchul Park, PhD, an assistant professor in the Dornsife School of Public Health. "It's not that rural patients were sicker than nonrural patients, they might just have a much tougher time than their counterparts did when it came to finding an approved medical provider."
Unlike traditional Medicare, which is administered by the Centers for Medicare and Medicaid Services, Medicare Advantage is operated by private companies approved by the government. Both traditional Medicare and Medicare Advantage include hospital (Part A) and medical (Part B) insurance. However, funding for the two programs differs and influences how they're delivered. In traditional Medicare, the federal government pays for services performed, but the government pays Medicare Advantage insurers using fixed, pre-negotiated rates. This creates incentive for Medicare Advantage plans to implement cost-saving measures, such as programs to keep their enrollees healthy, implement networks and require prior authorization restrictions to care.
"Medicare Advantage plans might have lower premiums and/or supplemental coverage in some areas, but that value is not enough for patients in more restrictive provider networks that prevent them from accessing care they need," said Park. "We found that levels of satisfaction with out-of-pocket costs had little very little influence in patients who decided to change their plan."
Data was gathered from a nationally representative sample of seniors over age 65 from the Medicare Current Beneficiary Survey from 2010-2016, (expect for 2014, when data was not reported), including demographics, socioeconomic characteristics, health data and satisfaction with care. Rural residency was based on county-level 2013 data from the Department of Agriculture.
The authors suggest the importance of developing policies to incentivize the health care workforce to practice in rural areas. For example, loan repayment or forgiveness programs may attract needed health care professionals to areas of shortages. Also, the federal government could consider changing Medicare Advantage network adequacy standards for rural areas to make sure that there are enough providers included. Finally, offering a rural payment add-on for Medicare Advantage plans that operate in rural areas may improve access to high-quality Medicare Advantage plans among rural enrollees.
INFORMATION:
In addition to Park, authors on this paper include David J. Meyers, PhD, of Brown University and senior author Brent A. Langellier, PhD, of Drexel's Dornsife School of Public Health.
This study was supported by a grant from the National Institute on Aging, National Institutes of Health.
Early exposure to tough conditions--particularly warmer waters and nightly swings of low oxygen--could leave lasting scars on oysters' ability to grow meaty tissue. A team of biologists at the Smithsonian Environmental Research Center (SERC) reported the discovery in a new study, published online Feb. 26 in the journal Ecological Applications.
Eastern oysters in Chesapeake Bay live mostly in shallow tributaries. It's a rough environment for shellfish that can't move. During hotter months, oxygen levels can swing drastically, from perfectly healthy ...
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases. These bispecific antibodies, which simultaneously bind to tumor antigens and T cells, cleared cancer cells without damaging healthy cells in mouse tumor models and/or cell culture experiments, across the three studies. The results highlight the therapeutic potential of this antibody type, which - unlike engineered immune cell therapies like CAR T - does not have to ...
In the middle of the Indian Ocean lies some of the last coral reef wilderness on Earth. The Chagos Archipelago, a collection of atolls, including Earth's largest - the Great Chagos Bank- is home to reefs that have been largely undisturbed by humans for the last 50 years. Some estimates indicate the Chagos Archipelago may contain more than half of the healthy coral reefs remaining in the entire Indian Ocean. These reefs are protected both by their remote location, and in one of the world's largest no-take marine reserves--the British Indian Ocean Territory (BIOT) marine protected area.
In 2015, scientists at the Khaled ...
Youth enrollment in Medicaid managed care across all states increased from 65 percent in 2000 to 94 percent in 2017.
Across the country, receipt of preventive care for youth in Medicaid managed care increased from 49 percent in 2000 to 59 percent in 2017, falling short of the 80 percent annual goal set by the Centers for Medicare and Medicaid Services (CMS).
Receipt of preventive care for youth in Medicaid managed care showed a significant increase in 17 states, a significant drop in six states, and no change in 28 states. Tennessee had the largest increase in preventive care associated with Medicaid managed care, while North Carolina showed the largest decrease.
Nationally, the number of children under age 21 enrolled in Medicaid grew from ...
A school-based cavity prevention program involving nearly 7,000 elementary school students reduced cavities by more than 50 percent, according to a study led by researchers at NYU College of Dentistry. The findings are END ...
White blood cells or lymphocytes are the soldiers of our immune system that patrol the body via the lymphatic system. While their primary role is to protect the body by scavenging invaders, they can sometimes go rogue and become the enemy. Lymphoma, a type of blood cancer, results from the uncontrolled proliferation of lymphocytes. They are classified as Hodgkins and Non-Hodgkins lymphomas on the basis of the cell of origin and clinical characteristics. Of them, diffuse large B-cell lymphoma (DLBCL) is the most common Non-Hodgkins lymphoma and is highly aggressive and fast-growing.
A combination of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment regimen for ...
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
Jon Weidanz, who also is a professor in the College of Nursing and Health Innovation at UTA, is the author of a perspective regarding the development of cancer immunotherapies.
His article, "Targeting cancer with bispecific antibodies," will appear in the March 5 edition of Science. It evaluates the findings of three studies by researchers at Johns Hopkins University and proposes that an emerging ...
In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.
Results of the Phase III clinical trial, conducted by an international team led by senior author Atul Malhotra, MD, research chief of pulmonary, critical care and sleep medicine at UC San Diego Health, found that tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
"Although our trial was negative based on primary outcomes, we did see some benefits, including an improvement in length of stay of eight days ...
In early 2020, daily life in Northern China slammed to a halt as the region entered a strict period of lockdown to slow the spread of COVID-19. Emissions from transportation and industry plummeted. Emissions of nitrogen oxides (NOx) from fossil fuels fell by 60 to 70 percent.
And yet, environmental researchers noticed that ground-level ozone pollution in Beijing and the Northern China Plain skyrocketed during this time period, despite the decrease of NOx, a component of ozone.
The region is no stranger to severe ozone pollution but until about five years ago, most ozone events occurred ...
CORVALLIS, Ore. - Oregon State University research has revealed a crucial mechanism behind one of humankind's most deadly physiological processes: the movement of malignant cells from one part of the body to another.
Published in the Proceedings of the National Academy of Sciences, the study led by OSU biophysicist Bo Sun shows the role that tissues' microscopic geometry plays in cancer metastasis, the internal spreading of the disease that's responsible for 95% of all cancer deaths.
To develop drugs that effectively combat metastasis, it's fundamentally important to understand what directs the metastatic process, Sun said.
"Our results show the level of tissue fiber alignment, particularly ...
